RT Journal Article
SR Electronic
T1 The effect of the COVID-19 lockdown on mental health care use in South Africa: an interrupted time series analysis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.07.22273561
DO 10.1101/2022.04.07.22273561
A1 Wettstein, Anja
A1 Tlali, Mpho
A1 Joska, John A
A1 Cornell, Morna
A1 Skrivankova, Veronika W
A1 Seedat, Soraya
A1 Mouton, Johannes P
A1 van den Heuvel, Leigh L
A1 Maxwell, Nicola
A1 Davies, Mary-Ann
A1 Maartens, Gary
A1 Egger, Matthias
A1 Haas, Andreas D
YR 2022
UL http://medrxiv.org/content/early/2022/04/11/2022.04.07.22273561.abstract
AB Aims In March 2020, South Africa introduced a lockdown in response to the COVID-19 pandemic, entailing the suspension of all non-essential activities and a complete ban of tobacco and alcohol sales. We studied the effect of the lockdown on mental health care utilisation rates in private-sector care in South Africa.Methods We did an interrupted time series analysis using insurance claims from January 1, 2017, to June 1, 2020 of beneficiaries 18 years or older from a large private sector medical aid scheme. We calculated weekly outpatient consultation and hospital admission rates for organic mental disorders, substance use disorders, serious mental disorders, depression, anxiety, other mental disorders, any mental disorder, and alcohol withdrawal syndrome. We calculated adjusted odds ratios (OR) for the effect of the lockdown on weekly outpatient consultation and hospital admission rates and the weekly change in rates during the lockdown until June 1, 2020.Results 710,367 persons were followed up for a median of 153 weeks. Hospital admission rates (OR 0.38; 95% CI 0.33–0.44) and outpatient consultation rates (OR 0.74; 95% CI 0.63–0.87) for any mental disorder decreased substantially after the lockdown and did not recover to pre-lockdown levels until June 1, 2020. Health care utilisation rates for alcohol withdrawal syndrome doubled after the introduction of the lockdown, but the statistical uncertainty around the estimates was large (OR 2.24; 95% CI 0.69-7.24).Conclusions Reduced mental health care contact rates during the COVID-19 lockdown likely reflect a substantial unmet need for mental health services with potential long-term consequences for mental health patients and their families. Steps to ensure access and continuity of mental health services during future lockdowns should be considered.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is supported by the US National Institutes of Health (the National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Cancer Institute, the National Institute of Mental Health, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the National Institute on Alcohol Abuse and Alcoholism, the National Institute of Diabetes and Digestive and Kidney Diseases, and the Fogarty International Center) under award number U01AI069924 (Drs Egger and Davies). Dr Haas was supported by an Ambizione Fellowship (award number 193381) and Dr Egger by special project funding (award number 189498) from the Swiss National Science Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Human Research Ethics Committee of the University of Cape Town and the Cantonal Ethics Committee of the Canton of Bern granted permission to analyse the dataI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data were obtained through the International epidemiology Database to Evaluate AIDS Southern Africa collaboration (IeDEA-SA, https://www.iedea-sa.org/). Data cannot be made available online because of legal and ethical restrictions. To request data, readers may contact IeDEA for consideration by filling out the online form available at https://www.iedea-sa.org/contact-us/ https://www.iedea-sa.org/